2.4.1.226: N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase
This is an abbreviated version!
For detailed information about N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase, go to the full flat file.
Word Map on EC 2.4.1.226
-
2.4.1.226
-
glycosaminoglycans
-
proteoglycans
-
tetrasaccharide
-
dermatan
-
polymerizing
-
csgalnact1
-
hyperelongation
-
brachydactyly
-
glcua
-
unsulfated
-
preaxial
-
medicine
- 2.4.1.226
- glycosaminoglycans
- proteoglycans
- tetrasaccharide
- dermatan
-
polymerizing
- csgalnact1
-
hyperelongation
- brachydactyly
-
glcua
-
unsulfated
-
preaxial
- medicine
Reaction
Synonyms
AcbD, ApCS, bifunctional CS synthase, ChGn-1, ChGn-2, chondroitin beta-glucuronyltransferase, chondroitin glucuronyltransaferase II, chondroitin glucuronyltransferase, chondroitin glucuronyltransferase II, chondroitin sulfate beta-1,4-N-acetylgalactosaminyltransferase-1, chondroitin sulfate glucoronyltransferase, chondroitin sulfate glucuronyltransferase, chondroitin sulfate glucuronyltransferase/chondroitin synthase-3, chondroitin sulfate N-acetylgalactosaminyltransferase-1, chondroitin sulfate N-acetylgalactosaminyltransferase-2, chondroitin sulfate synthase 1, chondroitin sulfate synthase-1, chondroitin sulfate synthase-2, chondroitin sulfate synthase-3, chondroitin synthase, chondroitin synthase-3, CHPF, ChSy, ChSy-1, ChSy-3, CHSY1, CHSY2, CHSY3, CS N-acetylgalactosaminyltransferase-1, CS synthase 1, CSGalNAcT-1, CSGlcA-T, CSGlcAT, CSGlcAT-II, CSGlcAT/ChSy-3, CSS1, CSS2, GlcAT-II, glucuronyltransferase, uridine diphosphoglucuronate-chondroitin, glucuronyltransferase-II, More, UDP-glucuronate:chondroitin glucuronyltransferase
ECTree
2.4.1.226 N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferaseAdvanced search results
results (
results (Substrates Products
Substrates Products on EC 2.4.1.226 - N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
SUBSTRATE 
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
NDP-glucose + 3-phospho-D-glycerate
NDP + 2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate
UDP-alpha-D-glucuronate + alpha-thrombomodulin
UDP + beta-D-glucuronosyl-(1,3)-alpha-thrombomodulin
-
-
-
?
UDP-alpha-D-glucuronate + beta-D-glucuronosyl-(1,3)-beta-D-galactosyl-(1,3)-beta-D-galactosyl-1,4-beta-D-xylose-1-O-Gly-Ser-Gly-Glu
UDP + ?
synthetic tetrasaccharide substrate
-
-
?
UDP-alpha-D-glucuronate + beta-D-glucuronosyl-(1,3)-beta-D-galactosyl-(1,3)-beta-D-galactosyl-1,4-beta-D-xylose-1-O-serine
UDP + ?
synthetic tetrasaccharide substrate
-
-
?
UDP-alpha-D-glucuronate + C11-oligosaccharide of chondroitin sulfate A
?
-
-
-
?
UDP-alpha-D-glucuronate + chondroitin sulfate A
UDP + beta-D-glucuronosyl-(1,3)-chondroitin sulfate A
and oligosaccharide of chondroitin sulfate with chain length of C11
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP-alpha-D-glucuronic acid + N-acetyl-D-galactosaminyl chondroitin polysaccharide
UDP + beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-chondroitin polysaccharide
polysaccharide substrate used after beta-glucuronidase treatment
-
-
?
UDP-GalNAc + 4-nitrophenyl D-glucuronide
UDP + 4-nitrophenyl 4-O-(N-acetyl-alpha-D-glucosaminyl)-D-glucuronide
UDP-glucuronic acid + chondroitin
UDP + N-acetylchondrosine glucuronic acid beta(1-3)N-acetylgalactosamine
UDP-glucuronic acid + chondroitin heptasaccharide
?
heptasaccharide having a N-acetylgalactosamine residue at its non-reducing terminus
-
-
?
UDP-glucuronic acid + chondroitin sulfate heptasaccharide
?
heptasaccharide having a N-acetylgalactosamine residue at its non-reducing terminus
-
-
?
NDP-glucose + 3-phospho-D-glycerate
NDP + 2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate
-
-
-
?
NDP-glucose + 3-phospho-D-glycerate
NDP + 2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate
-
-
-
?
NDP-glucose + 3-phospho-D-glycerate
NDP + 2-O-(alpha-D-glucopyranosyl)-3-phospho-D-glycerate
-
-
-
?
UDP-alpha-D-glucuronate + chondroitin
UDP + beta-D-glucuronosyl-(1,3)-chondroitin
-
-
-
?
UDP-alpha-D-glucuronate + chondroitin
UDP + beta-D-glucuronosyl-(1,3)-chondroitin
chondroitin polymerization in disaccharide units by glucuronyltransferase and N-acetylgalactosaminyltransferase activities of the enzyme
-
-
?
UDP-alpha-D-glucuronate + chondroitin
UDP + beta-D-glucuronosyl-(1,3)-chondroitin
and oligosaccharide of chondroitin with chain length of C11
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-glucuronosyl-proteoglycan
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
chondroitin sulfate A-8, chondroitin sulfate C-8,chondroitin-8, and GlcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-methoxy-phenyl as acceptor substrates
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
-
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
chondroitin sulfate A-8, chondroitin sulfate C-8,chondroitin-8, and GlcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-methoxy-phenyl as acceptor substrates
-
-
?
UDP-alpha-D-glucuronate + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan
-
-
-
-
?
UDP-GalNAc + 4-nitrophenyl D-glucuronide
UDP + 4-nitrophenyl 4-O-(N-acetyl-alpha-D-glucosaminyl)-D-glucuronide
-
-
-
?
UDP-GalNAc + 4-nitrophenyl D-glucuronide
UDP + 4-nitrophenyl 4-O-(N-acetyl-alpha-D-glucosaminyl)-D-glucuronide
-
-
-
?
UDP-GalNAc + 4-nitrophenyl D-glucuronide
UDP + 4-nitrophenyl 4-O-(N-acetyl-alpha-D-glucosaminyl)-D-glucuronide
-
-
-
?
UDP-glucuronic acid + chondroitin
UDP + N-acetylchondrosine glucuronic acid beta(1-3)N-acetylgalactosamine
-
-
-
?
UDP-glucuronic acid + chondroitin
UDP + N-acetylchondrosine glucuronic acid beta(1-3)N-acetylgalactosamine
-
-
-
-
?
UDP-glucuronic acid + chondroitin
UDP + N-acetylchondrosine glucuronic acid beta(1-3)N-acetylgalactosamine
-
-
-
?
UDP-glucuronic acid + chondroitin
UDP + N-acetylchondrosine glucuronic acid beta(1-3)N-acetylgalactosamine
-
-
-
?
UDP-glucuronic acid + chondroitin
UDP + N-acetylchondrosine glucuronic acid beta(1-3)N-acetylgalactosamine
-
-
-
?
additional information
?
-
GlcA with a para-nitrophenyl group can serve as the acceptor for ApCS. The enzyme shows a stringent donor tolerance when the acceptor is as small as this monosaccharide. Ligand/substrate interaction analysis via surface plasmon resonance (SPR) analysis. Substrate specificity, overview
-
-
-
additional information
?
-
-
GlcA with a para-nitrophenyl group can serve as the acceptor for ApCS. The enzyme shows a stringent donor tolerance when the acceptor is as small as this monosaccharide. Ligand/substrate interaction analysis via surface plasmon resonance (SPR) analysis. Substrate specificity, overview
-
-
-
additional information
?
-
GlcA with a para-nitrophenyl group can serve as the acceptor for ApCS. The enzyme shows a stringent donor tolerance when the acceptor is as small as this monosaccharide. Ligand/substrate interaction analysis via surface plasmon resonance (SPR) analysis. Substrate specificity, overview
-
-
-
additional information
?
-
GlcA with a para-nitrophenyl group can serve as the acceptor for ApCS. The enzyme shows a stringent donor tolerance when the acceptor is as small as this monosaccharide. Ligand/substrate interaction analysis via surface plasmon resonance (SPR) analysis. Substrate specificity, overview
-
-
-
additional information
?
-
-
further substrates: chondroitin heptaserine, pentaserine, non-sulfated odd-numbered oligosaccharides with a N-acetylgalactosamine residue at the non-reducing terminus except for a trisaccharide
-
-
?
additional information
?
-
-
no substrates: a trisaccharide-serine, an alpha-N-acetylgalactosamine-capped pentasaccharide-serine
-
-
?
additional information
?
-
-
the glucuronic acid transfer rate roughly increases with increasing chain length
-
-
?
additional information
?
-
-
6-O-sulfation of non-reducing terminal N-acetylgalactosamine markedly enhances glucuronic acid transfer
-
-
?
additional information
?
-
the glucuronic acid transfer rate roughly increases with increasing chain length
-
-
?
additional information
?
-
-
the glucuronic acid transfer rate roughly increases with increasing chain length
-
-
?
additional information
?
-
no substrates: chondroitin, chondroitin sulfate, dermatan sulfate, N-acetylheparosan, hyaluronan, heparan sulfate, heparin, hyaluronan heptasaccharides
-
-
?
additional information
?
-
-
no substrates: chondroitin, chondroitin sulfate, dermatan sulfate, N-acetylheparosan, hyaluronan, heparan sulfate, heparin, hyaluronan heptasaccharides
-
-
?
additional information
?
-
in vitro activity of the recombinant enzyme requires concomitant expression of the chondroitin polymerizing factor ChPF in a fusion protein, mixing of separately expressed proteins does not result in an active complex, overview
-
-
?
additional information
?
-
-
in vitro activity of the recombinant enzyme requires concomitant expression of the chondroitin polymerizing factor ChPF in a fusion protein, mixing of separately expressed proteins does not result in an active complex, overview
-
-
?
additional information
?
-
substrate specificities of enzymes CSGlcAT-II and CSS2 in truncated form
-
-
?
additional information
?
-
-
substrate specificities of enzymes CSGlcAT-II and CSS2 in truncated form
-
-
?
additional information
?
-
-
CSGlcA-T exhibits polymerization activity on alpha-thrombomodulin using alpha-thrombomodulin as acceptor incubated with UDP-Gal-NAc and UDP-GlcUA. The chain length of chondroitin formed by the co-expressed proteins ChSy-1,ChSy-2 (CSS3), or ChPF in various combinations is different
-
-
?
additional information
?
-
CSGlcA-T exhibits polymerization activity on alpha-thrombomodulin using alpha-thrombomodulin as acceptor incubated with UDP-Gal-NAc and UDP-GlcUA. The chain length of chondroitin formed by the co-expressed proteins ChSy-1,ChSy-2 (CSS3), or ChPF in various combinations is different
-
-
?
additional information
?
-
-
polymerization reactions carried out using alpha-thrombomodulin as an acceptor co-incubated with UDP-GalNAc and UDP-GlcA
-
-
?
additional information
?
-
polymerization reactions carried out using alpha-thrombomodulin as an acceptor co-incubated with UDP-GalNAc and UDP-GlcA
-
-
?
additional information
?
-
chondroitin synthase-1 has two glycosyltransferase activities: it acts as a GlcUA and a GalNAc transferase and is responsible for adding repeated disaccharide units to growing chondroitin sulfate chains
-
-
?
additional information
?
-
-
CHSY1, CHSY2 and CHSY3 possess dual, glucuronyltransferase and galactosaminyltransferase enzymatic activities, while the CSGlcA-T acts only by transferring glucuronic acid
-
-
?
additional information
?
-
-
CSS1, CSS2, and CSS3 contain two glycosyltransferase domains, beta-3 domain at the N-terminal region and beta-4 domain at the C-terminal region and exhibit dual enzymatic activities of N-acetylgalactosaminyltransferase-II, GalNAcTII, and glucuronyltransferase-II, GlcAT-II. Chondroitin sulfate glucuronyltransferase, similarly containing two glycosyltransferase domains, shows only GlcAT-I activity, EC 2.4.1.135
-
-
?
additional information
?
-
-
CSS2A exhibits both GalNAcT-II and GlcAT-II activities, CSS2B also shows both GalNAcT-II and GlcAT-II activities, but they are 82.8% and 26.5% that of CSS2A, respectively
-
-
?
additional information
?
-
-
CSS1, CSS2, and CSS3 contain two glycosyltransferase domains, beta-3 domain at the N-terminal region and beta-4 domain at the C-terminal region and exhibit dual enzymatic activities of N-acetylgalactosaminyltransferase-II, GalNAcTII, and glucuronyltransferase-II, GlcAT-II. Chondroitin sulfate glucuronyltransferase, similarly containing two glycosyltransferase domains, shows only GlcAT-I activity, EC 2.4.1.135
-
-
?
additional information
?
-
-
CSS2A exhibits both GalNAcT-II and GlcAT-II activities, CSS2B also shows both GalNAcT-II and GlcAT-II activities, but they are 82.8% and 26.5% that of CSS2A, respectively
-
-
?
